Skip navigation.

The School of Pharmacy, University of London



Dr Yingfen Hsia

Research Fellow, Centre for Paediatric Pharmacy Research

Tel: +44(0)20 7874 1538

Fax: +44 (0) 20 7387 5693

Email:

Areas of Expertise: pharmacy, pharmacoepidemiology

Research areas: pharmacoepidemiology, evidence synthesis

Biography

Dr. Yingfen Hsia is a qualified pharmacist in Taiwan. She spent 5 years working at the National Taiwan Hospital as a clinical pharmacist and one year as Research Coordinator for the Adverse Drug Reaction Reporting (ADR) system at the Taiwan Drug Relief Foundation. She was awarded an MSc in Clinical Pharmacy from the Taiwan National Cheng Kung University. Dr. Hsia recently completed her doctoral degree at the University of Surrey.

Dr. Hsia joined the Centre for Paediatric Pharmacy Research in September 2006. In October 2008- April 2009, she gained the position of epidemiologist at Cegedim EPIC. Dr. Hsia carries out paediatric research in the CPPR in collaboration with Cegedim EPIC.

Research Interests

Dr. Hsia’s main area of research is drug utilization in children and adolescents. She has many years of experience using primary care databases including the UK General Practice Research Database (GPRD), IMS DA, and The Health Improvement Network (THIN). She is also interested in evidence synthesis in particular child-relevant systematic review.

Selected Publication

1. Hsia YF, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK. European Journal of Epidemiology. 2009;24(4):211-6.

2. Hsia YF, Neubert A.C., Rani F, Viner RM, Hindmarsh PC, Wong ICK, An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. British Journal of Clinical Pharmacology. 2009: 67(2): 242-249.

3. Hsia YF, Neubert A, Sturkenboom M, Verhamme KMC, Sen EF, Giaquinto C.,Ceci A., Murray ML., Wong ICK on behalf of the TEDDY Network of Excellence. Antiepileptic drug prescribing comparison in three European countries. Epilepsia 2009 Oct 8 [Epub ahead of print].

4. Viner R.M, Hsia YF, Antje C Neubert, ICK Wong. Rise in anti-obesity drug prescribing in children and adolescents in the UK: a population-based study. British Journal of Clinical Pharmacology, 2009 (in print).

5. Viner R.M., Hsia YF, Tomsic T., Wong ICK. Efficacy and Safety of Anti-Obesity Drugs in Children and Adolescents: Systematic Review and Meta-analysis. Obesity Reviews 2009 Nov 17. [Epub ahead of print].

  

To top